{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:16:07Z","timestamp":1783113367810,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016747","name":"Mercer University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["R01CA236843"],"award-info":[{"award-number":["R01CA236843"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbrc.2026.154011","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:09:29Z","timestamp":1779466169000},"page":"154011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Human PRSS8 functions as a targetable, endogenous TGFBR3 sheddase via the novel cholesterol-PRSS8-TGF-\u03b2 axis"],"prefix":"10.1016","volume":"826","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-4548","authenticated-orcid":false,"given":"Benjamin M.","family":"Greulich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1023-7821","authenticated-orcid":false,"given":"John","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-2944","authenticated-orcid":false,"given":"John","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Eidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Fitzgibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Garver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Karas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8978-5946","authenticated-orcid":false,"given":"Cion","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Sudakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard C.","family":"Blobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154011_bib1","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154011_bib2","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1158\/0008-5472.CAN-07-0035","article-title":"Loss of betaglycan expression in ovarian cancer: role in motility and invasion","volume":"67","author":"Hempel","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154011_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8110100","article-title":"T\u03b2RIII expression in human breast cancer stroma and the role of soluble T\u03b2RIII in breast cancer associated fibroblasts","volume":"8","author":"Jovanovi\u0107","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154011_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom9110743","article-title":"A perspective on the development of TGF-\u03b2 inhibitors for cancer treatment","volume":"9","author":"Huynh","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.154011_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fcell.2020.00605","article-title":"On-Target Anti-TGF-\u03b2 therapies are not succeeding in clinical cancer treatments: what are remaining challenges?","volume":"8","author":"Teixeira","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.154011_bib6","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011197","article-title":"Signaling by the TGF\u03b2 superfamily","volume":"5","author":"Wrana","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrc.2026.154011_bib7","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/emboj\/19.8.1745","article-title":"Transcriptional control by the TGF-beta\/Smad signaling system","volume":"19","author":"Massagu\u00e9","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.154011_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbadis.2009.07.003","article-title":"The emerging role of TGF-beta superfamily coreceptors in cancer","volume":"1792","author":"Bernabeu","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.154011_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massagu\u00e9","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2026.154011_bib10","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1083\/jcb.109.6.3137","article-title":"Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta","volume":"109","author":"Andres","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154011_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/dvdy.338","article-title":"TGF-\u03b2 superfamily co-receptors in cancer","volume":"251","author":"Pawlak","year":"2022","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbrc.2026.154011_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI29293","article-title":"The type III TGF-beta receptor suppresses breast cancer progression","volume":"117","author":"Dong","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154011_bib13","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1091\/mbc.e13-09-0524","article-title":"Ectodomain shedding of T\u03b2RIII is required for T\u03b2RIII-mediated suppression of TGF-\u03b2 signaling and breast cancer migration and invasion","volume":"25","author":"Elderbroom","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2026.154011_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neo.2014.05.008","article-title":"The balance of cell surface and soluble type III TGF-\u03b2 receptor regulates BMP signaling in normal and cancerous mammary epithelial cells","volume":"16","author":"Gatza","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbrc.2026.154011_bib15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/0008-5472.CAN-06-3117","article-title":"The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer","volume":"67","author":"Turley","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154011_bib16","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1074\/jbc.M306499200","article-title":"The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1","volume":"279","author":"Velasco-Loyden","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154011_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00018-014-1733-x","article-title":"Proteolytic control of TGF-\u03b2 co-receptor activity by BMP-1\/tolloid-like proteases revealed by quantitative iTRAQ proteomics","volume":"72","author":"Delolme","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.154011_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101372","article-title":"Exploring TGFBR3 in disease pathogenesis: mechanisms, clinical implications, and pharmacological modulation","volume":"16","author":"Song","year":"2026","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bbrc.2026.154011_bib19","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1172\/JCI65745","article-title":"Type III TGF-\u03b2 receptor downregulation generates an immunotolerant tumor microenvironment","volume":"123","author":"Hanks","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154011_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1593\/neo.11528","article-title":"Type III TGF-\u03b2 receptor enhances colon cancer cell migration and anchorage-independent growth","volume":"13","author":"Gatza","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbrc.2026.154011_bib21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cellsig.2010.01.016","article-title":"Roles for the type III TGF-beta receptor in human cancer","volume":"22","author":"Gatza","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.154011_bib22","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1016\/S0021-9258(17)32244-5","article-title":"Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland","volume":"269","author":"Yu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154011_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13811","article-title":"ENaC activation by proteases","volume":"235","author":"Anand","year":"2022","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bbrc.2026.154011_bib24","doi-asserted-by":"crossref","first-page":"32941","DOI":"10.1074\/jbc.C600208200","article-title":"Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation","volume":"281","author":"Netzel-Arnett","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154011_bib25","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/93.19.1458","article-title":"Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology","volume":"93","author":"Mok","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrc.2026.154011_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.10346","article-title":"Regulation of prostasin expression and function in the prostate","volume":"59","author":"Chen","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2026.154011_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/1471-2407-9-377","article-title":"Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT)","volume":"9","author":"Chen","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154011_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.1601","article-title":"Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation","volume":"97","author":"Chen","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154011_bib29","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s11010-021-04128-y","article-title":"A tumor-promoting role for soluble T\u03b2RIII in glioblastoma","volume":"476","author":"Burghardt","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.154011_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.786728","article-title":"TGF-\u03b2 signaling and resistance to cancer therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.154011_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3816\/CLC.2002.n.009","article-title":"Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patients","volume":"3","author":"Adonizio","year":"2002","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.bbrc.2026.154011_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3389\/fonc.2020.00793","article-title":"Oral chemotherapy for treatment of lung cancer","volume":"10","author":"Jonna","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.154011_bib33","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.7150\/jca.94109","article-title":"Revisiting Temozolomide's role in solid tumors: old is gold?","volume":"15","author":"Matthaios","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154011_bib34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/onc.2009.426","article-title":"Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis","volume":"29","author":"Petersen","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154011_bib35","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1172\/JCI90439","article-title":"CCT6A suppresses SMAD2 and promotes prometastatic TGF-\u03b2 signaling","volume":"127","author":"Ying","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154011_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102820","article-title":"Smad2\u0394exon3 and Smad3 have distinct properties in signal transmission leading to TGF-\u03b2-induced cell motility","volume":"299","author":"Yokoyama","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154011_bib37","doi-asserted-by":"crossref","first-page":"21434","DOI":"10.1074\/jbc.M011423200","article-title":"Prostasin is a glycosylphosphatidylinositol-anchored active serine protease","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154011_bib38","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00637.2005","article-title":"Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor","volume":"291","author":"Verghese","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2026.154011_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13640","article-title":"Zymogen-locked mutant prostasin (Prss8) leads to incomplete proteolytic activation of the epithelial sodium channel (ENaC) and severely compromises triamterene tolerance in mice","volume":"232","author":"Essigke","year":"2021","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bbrc.2026.154011_bib40","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbrc.2006.06.049","article-title":"Mechanisms of sterol regulatory element-binding protein-2 (SREBP-2) regulation of human prostasin gene expression","volume":"346","author":"Chen","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154011_bib41","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1080\/21655979.2021.1978615","volume":"12","author":"Cai","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbrc.2026.154011_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1194\/jlr.C066712","article-title":"Srebp2: a master regulator of sterol and fatty acid synthesis","volume":"57","author":"Madison","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2026.154011_bib43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bbrc.2026.154011_bib44","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154011_bib45","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1021\/bi901528w","article-title":"Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor","volume":"48","author":"Mendoza","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2026.154011_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bbrc.2004.09.123","article-title":"Biochemical characterization of prostasin, a channel activating protease","volume":"324","author":"Shipway","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154011_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2042098612439884","article-title":"Safety of statins: an update","volume":"3","author":"Hu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.bbrc.2026.154011_bib48","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The role of cholesterol in cancer","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154011_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105453","article-title":"A complex with poly(A) binding protein and EWS facilitates the transcriptional function of oncogenic ETS transcription factors in prostate cells","author":"Greulich","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154011_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaa046","article-title":"Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target","volume":"3","author":"Greulich","year":"2021","journal-title":"NAR Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:18:35Z","timestamp":1783109915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26007758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0006291X26007758"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154011","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human PRSS8 functions as a targetable, endogenous TGFBR3 sheddase via the novel cholesterol-PRSS8-TGF-\u03b2 axis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154011"}}